The nationwide initiative will fund nine city projects aimed at ending preventable maternal deaths.

John Furey helped propel Spark to a groundbreaking FDA approval. Can he do the same for another Philly biotech company?

Now is not the time to back away from the women in your office.

Proscia has developed software and artificial intelligence tools to make pathology more accurate and efficient.

D’IYANU founder and CEO Adesola Elabor didn’t want to waste any more time doing what she didn’t enjoy.

Spark Therapeutics board member Steve Altschuler shares his thoughts on the challenges of big pharma acquisitions.

The two local companies are combining new tech and genetic testing to improve outcomes for patients.

What our new downtown mall, opening this month, will tell us about the fate of Philly retail.

The chair of Morgan, Lewis & Bockius talks about the importance of employee health and happiness.

The sports leader, who recently landed a multi-year contract extension, on making the transition from player to coach and his goals for the rest of the season.

The first-of-its-kind space boasts a 25,000-square-foot training facility that could help close the local bioprocessing workforce gap.

The funding from the U.S. Department of Commerce will bring more than $1 million and 100 jobs to the region.

Since email is no longer cutting it and phone calls just won’t do, get ready for autocorrect to make a name for itself in the job recruitment process.

The company’s personalized genetic testing service could help clinicians more accurately diagnose and treat an array of mental health conditions.

With its free summer programs at the Science Center, FirstHand could lead more youth to careers in science.